June 09, 2025 08:00 ET | Source: PDS Biotechnology Corporation Event to Discuss the Changing Landscape of HNSCC in context…
VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…